Richard L Doty1, Vidyulata Kamath2. 1. Department of Otorhinolaryngology: Head and Neck Surgery, Smell and Taste Center, Perelman School of Medicine, University of Pennsylvania Philadelphia, PA, USA. 2. Department of Otorhinolaryngology: Head and Neck Surgery, Smell and Taste Center, Perelman School of Medicine, University of Pennsylvania Philadelphia, PA, USA ; Division of Medical Psychology, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Baltimore, MD, USA.
Abstract
Decreased olfactory function is very common in the older population, being present in over half of those between the ages of 65 and 80 years and in over three quarters of those over the age of 80 years. Such dysfunction significantly influences physical well-being and quality of life, nutrition, the enjoyment of food, as well as everyday safety. Indeed a disproportionate number of the elderly die in accident gas poisonings each year. As described in this review, multiple factors contribute to such age-related loss, including altered nasal engorgement, increased propensity for nasal disease, cumulative damage to the olfactory epithelium from viral and other environmental insults, decrements in mucosal metabolizing enzymes, ossification of cribriform plate foramina, loss of selectivity of receptor cells to odorants, changes in neurotransmitter and neuromodulator systems, and neuronal expression of aberrant proteins associated with neurodegenerative disease. It is now well established that decreased smell loss can be an early sign of such neurodegenerative diseases as Alzheimer's disease and sporadic Parkinson's disease. In this review we provide an overview of the anatomy and physiology of the aging olfactory system, how this system is clinically evaluated, and the multiple pathophysiological factors that are associated with its dysfunction.
Decreased olfactory function is very common in the older population, being present in over half of those between the ages of 65 and 80 years and in over three quarters of those over the age of 80 years. Such dysfunction significantly influences physical well-being and quality of life, nutrition, the enjoyment of food, as well as everyday safety. Indeed a disproportionate number of the elderly die in accident gas poisonings each year. As described in this review, multiple factors contribute to such age-related loss, including altered nasal engorgement, increased propensity for nasal disease, cumulative damage to the olfactory epithelium from viral and other environmental insults, decrements in mucosal metabolizing enzymes, ossification of cribriform plate foramina, loss of selectivity of receptor cells to odorants, changes in neurotransmitter and neuromodulator systems, and neuronal expression of aberrant proteins associated with neurodegenerative disease. It is now well established that decreased smell loss can be an early sign of such neurodegenerative diseases as Alzheimer's disease and sporadic Parkinson's disease. In this review we provide an overview of the anatomy and physiology of the aging olfactory system, how this system is clinically evaluated, and the multiple pathophysiological factors that are associated with its dysfunction.
The sense of smell determines our ability to perceive thousands of odors, including ones associated with such hazards as leaking natural gas, fire, and spoiled food. This important sense mediates, to a large degree, the flavor of foods and beverages and significantly enhances quality of life. We use this sense to confirm that our clothes, homes, and offices are clean, and to fully enjoy flowers, perfumes, festive occasions, personal care products, and nature (e.g., the mountains and the sea shore). It is perhaps not surprising, then, that smell loss or disordered smell function significantly impacts our safety, appetite, nutrition, and physical and mental well-being.Cross-sectional studies suggest that about half of the United States population between 65 and 80 years of age has demonstrable smell loss and that, over the age of 80, approximately three-quarters experience such loss (Doty et al., 1984a; Duffy et al., 1995; Murphy et al., 2002). Somewhat lower prevalence estimates are seen in very healthy cohorts (Ship and Weiffenbach, 1993; Doty et al., 2011) and in some other populations (Bramerson et al., 2004; Karpa et al., 2010), although test methods and criteria for defining dysfunction vary considerably among studies. As a result of survivor bias and other factors, cross-sectional studies likely underestimate the prevalence of age-related olfactory dysfunction, and longitudinal studies are needed to determine incidence rates and individual changes that may occur over time from factors that damage the olfactory system (London et al., 2008). With rare exception (e.g., Schubert et al., 2011), few longitudinal studies have focused on olfactory function, per se, with most having the goal of detecting incipient dementia or other neurological disorders in older cohorts (Graves et al., 1999; Devanand et al., 2000; Wilson et al., 2007b; Herting et al., 2008; Olofsson et al., 2008, 2009; Ross et al., 2008; Schubert et al., 2008; Conti et al., 2013; Iranzo et al., 2013; Velayudhan et al., 2013). However, regardless of whether cross-sectional or longitudinal tests are employed, age-related decrements are robust and, as described later in this review, are detectable by any number of olfactory tests, including ones employing psychophysical, electrophysiological, and psychophysiological procedures. Results from most such tests are strongly correlated, reflecting, in large part, mutual dependence upon the integrity of common elements of the olfactory pathways.The consequences of olfactory dysfunction are staggering. In addition to explaining why many older persons complain that food lacks flavor (Schiffman and Zervakis, 2002), decreased ability to smell is largely responsible for the disproportionate number of elderly who die in accidental gas poisonings and explosions each year. In Britain, ~10% of all accidental deaths in the home between 1931 and 1956 occurred from coal-gas poisoning, with the majority occurring in persons over the age of 60 years (Chalke et al., 1958). Stevens et al. have estimated that 45% of older adults are unable to detect petroleum gas diluted to the level dictated by safety standards, as compared to only 10% of younger adults (Stevens et al., 1987). In a 2004 study of 445 patients with chemosensory dysfunction, a number of whom were elderly, 37% of those with olfactory impairment reported having experienced an olfaction-related hazardous event at some point in their lives, as compared to only 19% of those with no such impairment. Cooking-related incidents were most common (45%), with ingestion of spoiled food (25%), lack of ability to detect leaking natural gas (23%), and inability to smell a fire (7%) being less frequent (Santos et al., 2004). One longitudinal study of 1162 older individuals without dementia found that the mortality risk was 36% higher in those with low scores on a smell test after adjusting for such variables as sex, age, and education (Wilson et al., 2011a).This review addresses the functional and pathological changes that occur in the olfactory system as a result of age. The influences of age-related diseases on olfaction, such as Alzheimer's and Parkinson's disease, are briefly mentioned but not reviewed in detail; the reader is referred elsewhere for recent reviews of such influences (Barresi et al., 2012; Doty, 2012a,b). To provide a template for understanding the neural underpinnings of age-related changes in olfaction, we first provide an overview of basic olfactory anatomy and physiology. This is followed by the types of changes that are observed on a range of functional tests and their anatomical and neuropathological correlates.
Basic anatomy and physiology of the nose and olfactory system
The human nose is comprised of two separate nasal passages separated by a septum. An external opening, termed the naris or nostril, enters into each chamber. Extending from the lateral walls of the chambers are nasal turbinates, cartilaginous structures that are covered with a highly vascularized epithelium which serves to warm, humidify, and cleanse the air (Frye, 2003). The latter is achieved by creating turbulent flow, largely as a result of a narrowing of the cavity close to the aperture of each naris (the nasal valve). The turbulence drives particulate and other airborne matter onto the nasal mucus which is continuously moved to the gut via respiratory cilia that beat in unison (Schwab and Zenkel, 1998). Damage to respiratory cilia is associated with bacterial build-up and other problems that can impair nasal function and, ultimately, the ability to smell (Cohen, 2006).Before an odorant is able to initiate the neural activity responsible for smell perception, it must first enter the nasal cavity from either the nares or from the nasal pharynx (i.e., from the mouth) and be absorbed into the mucus covering the olfactory epithelium. This mucus, which differs in composition from that of the mucus within the nasal cavity proper, is largely derived from specialized Bowman's glands (Getchell and Getchell, 1992). Among its secretions are odorant-binding proteins that shepherd the transit of hydrophobic odorants to the olfactory receptors (Pelosi, 1994), growth factors associated with mitosis and other cell-related processes (Federico et al., 1999), numerous immune factors (Gladysheva et al., 1986), and biotransformation enzymes involved in not only odorant clearance, but in destruction of viruses and bacteria, degradation of pro-inflammatory peptides, and toxicant metabolism (Ding and Dahl, 2003).The cells of the olfactory epithelium are derived embryologically from both the olfactory placode and the neural crest (Katoh et al., 2011). This specialized epithelium, which lines the upper regions of the septum, cribriform plate, superior turbinate, and sectors of the middle turbinate (Leopold et al., 2000), is innervated not only by olfactory receptor cells, but by fibers from the trigeminal nerve, the nervus terminalis (Cranial Nerve 0), and autonomic fibers from the superior cervical ganglion (Zielinski et al., 1989). In addition to the receptor cells, whose cilia differ from those elsewhere in the nose in lacking dynein arms and intrinsic motility, this epithelium is comprised of sustentacular (supporting) cells, microvillar cells, basal cells, and duct cells from the Bowman's glands (Menco and Morrison, 2003). Sustentacular cells add structural support to the epithelium and, among other things, insulate receptor cells from one another. These cells are also involved in the biotransformation of noxious chemicals and maintenance of the ionic milieu that surrounds the olfactory receptor cell cilia (Vogalis et al., 2005). Two morphologically distinct types of basal cells are recognized—electron-dense horizontal cells that express cytokeratin and electron-lucent globose cells which do not express cytokeratin (Mackay-Sim, 2010). It is from these multipotent stem cells, most notably the horizontal cells, that the olfactory receptor and other cell types germinate (Iwai et al., 2008). When damaged, the olfactory epithelium can be reconstituted from these cells, although the success of such regeneration is influenced by age-related processes such as telomere shortening (Watabe-Rudolph et al., 2011) and the degree of cumulative damage from prior environmental insults, including those from pollution and viral and bacterial infections (Harkema et al., 2006). The rate of mitosis of the basal cells is regulated by multiple processes, including local cell density, resident macrophages, neural activity, and damage to olfactory sensory neurons (Camara and Harding, 1984; Mackay-Sim and Patel, 1984; Borders et al., 2007). Biochemical and mechanical stress contribute to the sensory neuron differentiation from the basal cells (Feron et al., 1999). A cross-section of the olfactory epithelium is depicted in Figure 1A, whereas the ciliated surface is depicted in Figure 1B.
Age-related olfactory loss in humans and its quantification
Quantitative testing of the sense of smell, which is easy to perform in the clinic, is critical for identifying the nature and degree of smell dysfunction experienced by older persons. Many elderly fail to recognize their deficit or, when they do so, either overestimate or underestimate its magnitude. Importantly, a significant number complain of taste loss, not recognizing the primary contribution of olfaction in determining the flavor of their food. Based on quantitative testing, the clinician can inform many patients that their function, while diminished in an absolute sense, is still well above that of most of their peers, a point that provides considerable solace to those groping with the multiple changes that accompany the aging process.Age-related deficits in olfactory function are detected by a number of types of olfactory tests, including psychophysical tests (e.g., tests of odor detection, identification, discrimination, memory, and suprathreshold intensity), electrophysiological tests (e.g., odor event-related potentials), and psychophysiological tests (e.g., odor-related changes in heart rate and respiration). All such tests generally detect age-related decrements in the olfactory system. Since hundreds of studies have documented such decrements, only selected examples are presented here.
Psychophysical tests
Deficits observed in older persons have been most commonly detected using psychophysical tests—tests that require a conscious response on the part of the patient. With the possible exception of some measures of suprathreshold intensity and pleasantness, the results from the majority of psychophysical tests are positively correlated with one another (Doty et al., 1994; Koskinen et al., 2004), with the size of the correlations between any two tests being bounded by the reliability coefficient of the less reliable test (Doty et al., 1995). Thus, the weight of the evidence suggests that individuals have a “general olfactory acuity” factor similar to the general intelligence factor proposed for various tests of intelligence (Yoshida, 1984; Doty et al., 1994). Despite this evidence, and the fact that comparison of results from nominally disparate olfactory tests is confounded by differing reliabilities, odorants, non-olfactory task demands, and operational procedures, for heuristic reasons age-related deficits are described below for nominally distinct classes of tests. As will be seen, age-related effects are found regardless of the employed measuring instrument, although, in general, longer tests are more reliable and, hence, more sensitive to such deficits (Doty et al., 1995).The most widely used psychophysical tests are identification tests. A number of identification tests, such as the 40-item University of Pennsylvania Smell Identification Test (UPSIT; Figure 3) and its briefer 12-item version (the Brief Smell Identification Test or B-SIT), can be self-administered. In such tests familiar odorants are presented and the subject is required to identify the name of the odor from written alternatives or, in some cases, to choose a picture that depicts the source of the odor (Doty et al., 1984b, 1996; Richman et al., 1992; Kobal et al., 1996; Hummel et al., 1997; Nordin et al., 2002; Kobayashi et al., 2006; Krantz et al., 2009; Cameron and Doty, 2013). In addition to absolute determination of function (e.g., normal or mild, moderate, severe, or total loss), sex- and age-related normative data are available for some such tests, making it possible to determine a patient's percentile rank relative to peers (Doty, 1995). Odor identification tests are clearly sensitive to age-related decrements in the ability to smell (Doty et al., 1984a, 2011; Cain and Stevens, 1989; Cain and Gent, 1991; Schiffman, 1991; Ship et al., 1996; Griep et al., 1997; Kaneda et al., 2000; Larsson et al., 2000; Murphy et al., 2002; Larsson et al., 2004; Calhoun-Haney and Murphy, 2005; Schumm et al., 2009; Hedner et al., 2010a,b; Olofsson et al., 2010; Wong et al., 2010; Schubert et al., 2011, 2012; Wehling et al., 2011; Wilson et al., 2011a; Menon et al., 2013; Pinto et al., 2013). Because a number of odors are not universally recognized, identification tests are often adjusted to contain odorants and response alternatives familiar to those in a given culture. An example of the prototypical age-related decrement present in odor identification is shown in Figure 4 (Doty et al., 1984a).
Odor-induced recordings have been obtained from electrodes placed near or on the olfactory epithelium, producing a summated negative potential termed the electro-olfactogram (EOG) (Hosoya and Yashida, 1937; Ottoson, 1956). EOG magnitude is proportional to stimulus concentration and is correlated with perceived intensity, although it can be present even after death, suggesting it alone cannot be relied upon as a measure of odor perception, per se. Recording can be tedious and activity in one area of the olfactory epithelium is not necessarily representative of activity in other areas. Although one can surmise from the age-related general decreases in the integrity of the olfactory epithelium that EOGs would be expected to be smaller, to our knowledge no such study has been performed. It is noteworthy, however, that EOG activity is found on the anterior surface of the middle turbinate and a few millimeters below the anterior insertion of the middle turbinate, suggesting, along with biopsy samples, that the olfactory epithelium extends farther forward in some people than traditionally believed (Leopold et al., 2000).A more practical electrophysiological procedure is the measurement of odor-induced electrical activity at the level of the scalp (e.g., the odor event-related potential or OERP). This activity reflects odor-related changes induced in electrical fields generated by large populations of cortical neurons (Gevins and Remond, 1987). However, the signals are small (<50 μV), can be difficult extract from the background EEG, and require complex stimulus presentation equipment (Figure 8). In one study, for example, OERPs were not identifiable in nearly a third of subjects with no olfactory deficits (Lotsch and Hummel, 2006). Nevertheless, age-related alterations in the latency and amplitude of OERPs have been observed, with older persons typically exhibiting longer N1 latencies and smaller N1 and P2 amplitudes (Figure 9) (Murphy et al., 1994; Evans et al., 1995; Hummel et al., 1998; Covington et al., 1999; Thesen and Murphy, 2001; Stuck et al., 2006; Morgan and Murphy, 2010). Although classic procedures analyze only time-locked potentials, recently developed procedures combine traditional EEG and OERP methodology to assess activity within both time and frequency domains (Huart et al., 2012; Osman and Silas, 2014). Age-related responses using these newer methods have yet to be assessed.
Figure 8
Air-dilution olfactometer used to present pulses of odorants into a purified and humidified airstream directed through nares of a subject. This device ensures that the odor event-related potentials (OERPs) are not confounded by somatosensory artifacts due to alterations in stimulus pressure, temperature, or other factors. Photo courtesy of the University of Pennsylvania Smell and Taste Center, Philadelphia, PA.
Psychophysiological tests are tests which measure mainly autonomic nervous system responses to stimuli, in this case odor. Among such measures are changes in heart rate (Bensafi et al., 2002), blood pressure (Nagai et al., 2000), respiration (Kleemann et al., 2009), and skin conductance (Møller and Dijksterhuis, 2003). In the case of the nose, cardiovascular and respiratory changes can reflect activity of the trigeminal nerve (CN V), rather than the olfactory nerve (CN I), limiting in some cases the usefulness of such tests (Allen, 1928).A recently developed test measures a basic respiratory response to smelling an unpleasant odor (Frank et al., 2003, 2004, 2006). In this test, called the Sniff Magnitude Test, the subject sniffs a canister. Upon the initiation of the sniff, which is detected by air pressure changes sensed by cannulas positioned just inside the nose, the canister opens and either odorless air or a bad smelling odorant (e.g., methylthiobutyrate or ethyl 3-mercaptoproprionate) is released. Persons with a good sense of smell immediately stop sniffing, whereas those with a poor sense of smell take longer to inhibit their sniff or, if anosmic, may not inhibit their inhalation at all (Tourbier and Doty, 2007). The magnitude and duration of the sniff is assessed by a computer and a ratio computed between the area of the sniff pressure-time curve on odorant trials to that on blank air trials. Like other olfactory measures, this measure is sensitive to age-related olfactory changes (Figure 10) (Frank et al., 2006).
It seems intuitive that structural changes would be present in the aging nose and olfactory system that would explain the functional declines observed in older persons. Indeed, as described below, a number of age-related alterations within the nose, olfactory epithelium, bulb, and higher brain structures have been associated to one degree or another with olfactory dysfunction. Moreover, several genes have been found to contribute, albeit to a modest degree, to the age-related decline in odor identification. For example, persons over the age of 70 who are homozygous for the val allele of the val66met polymorphism of brain derived neurotrohic factor (BDNF) exhibit a somewhat greater 5-year decline in odor identification performance than persons heterozygous for this allel (v/m) or homozygous for the met allel (m/m) (Hedner et al., 2010b). Older carriers of the ε4-allele of the humanapolipoprotein E gene, a plasma protein involved in lipid transport, exhibit greater longitudinal declines in odor identification than non-carriers (Calhoun-Haney and Murphy, 2005). This occurs even after controlling for the effects of vocabulary and general cognitive status, suggesting that the influences of this allele on odor identification ability are independent of clinical dementia (Olofsson et al., 2010).More recently, Doty et al. tested the odor identification ability of 1222 very old twins and singletons, including 91 centenarians (Doty et al., 2011). Unlike cognition, the sex- and age-adjusted heritability coefficients for odor identification from the two genetic models employed were quite low (i.e., 0.13 and 0.16 compared to 0.70 for cognition). These authors point out that nearly all twin studies looking at middle aged or older study cohorts report low heritability coefficients, in contrast to studies in which only young cohorts are assessed. One explanation for this observation is that the initial effects of heritability on function are eventually swamped by other factors in older persons, including the cumulative environmental insults to the olfactory epithelium, as described below.
Changes in non-olfactory elements of the nose
Odorant access to the olfactory receptors can be altered by age-related changes in nasal airflow patterns and mucous composition, including those associated with diseases which are more common in the elderly. The prevalence of chronic rhinosinusitis, nasal polyposis, and lessened mucocilliary clearance increases with age (Settipane, 1996; Cho et al., 2012), as does nasal resistance, as measured by rhinomanometry (Edelstein, 1996). The nasal epithelium undergoes age-related atrophy, decreases in mucosal blood flow, and decrements in elasticity (Somlyo and Somlyo, 1968; Bende, 1983). In general, older persons report experiencing more frequent episodes of postnasal drip, nasal drainage, sneezing, and coughing than younger ones (Edelstein, 1996). Interestingly, increased age is associated with a significant decrease in asthma (Jarvis et al., 2012) and a number of abnormalities of the nasopharynx, such as adenoidal hypertrophy, inflammation, cystic degeneration, or thick mucus discharge (Edelstein, 1996). Recently it has been shown that sleep apnea, a disorder associated with restriction of nasal airflow that increases in prevalence with age, has an adverse effect on smell function (Salihoglu et al., 2013).It must not be forgotten that the nose is a dynamic organ. Airflow patterns are regularly shifting, reflecting multiple influences on nasal turbinate engorgement and secretory activity from air temperature, humidity, physical activity, psychological stress, and environmental xenobiotics such as allergens, nanoparticles, toxic chemicals, and infectious agents (Frye, 2003). Nasal engorgement is regulated in large degree by the autonomic nervous system. Thus, relative sympathetic/parasympathetic dominance influences the lateralized changes in engorgement of the nasal capillary bodies that occur over time. Although reciprocal and cyclic left:right fluctuations in relative airflow—termed the nasal cycle—are not as common as previously believed (Gilbert, 1989; Mirza et al., 1997), there is evidence that olfactory sensitivity is somewhat higher during the so-called sympathetic phase of this putative cycle, i.e., when the left side of the nose is relatively more engorged than the right (Frye and Doty, 1992). Since nearly three-quarters of adults over the age of 50 no longer exhibit this cycle (Mirza et al., 1997), a subtle lowering of olfactory sensitivity could mark the transition from the predominance of relative more sympathetic dominance to a more balanced sympathetic/parasympathetic mode. Age-related changes the suprachiasmatic nucleus, a brain center involved in the control of a number of biological rhythms, could conceivably account for this effect (Farajnia et al., 2014).An important non-neural process that undoubtedly compromises smell function is the age-related decline in the size and number of patent foramina of the cribriform plate (Krmpotic-Nemanic, 1969; Kalmey et al., 1998). The occlusion or decrement in size of these holes can lead to a pinching off or elimination of olfactory receptor cell axons that enter into the brain from the olfactory epithelium (Figure 11). Kalmey et al. found a 47.3% reduction of the area of the foramina within the posterior centimeter of the cribriform plate in men older than 50 years relative to those younger than this age (7.19 vs. 3.79 mm2) (Kalmey et al., 1998). The reduction in women was 28.8% (5.61 vs. 3.99 mm2).
Histological studies of the human olfactory epithelium have shown age-related changes in its nature and integrity, including decreased number of receptors, a thinning of the epithelium in general, and alterations in the cellular patterns and zonal distributions of the nuclei of the olfactory receptor and sustentacular cells. Intermingling of supporting and receptor cell nuclei are common, as is intercalation of respiratory epithelium with that of the olfactory epithelium, reflecting replacement of the olfactory epithelia with respiratory epithelia (Naessen, 1971; Nakashima et al., 1984; Morrison and Costanzo, 1990; Paik et al., 1992) (Figure 12). Similar alterations are noted in rodents exposed to olfactory toxins such as 3-methyl indole and 3-trifluoromethyl pyridine (Gaskell et al., 1990; Peele et al., 1991). In infancy and early childhood, the olfactory epithelium is highly vascularized, with blood capillaries being found in its basal layers and in close association with the perikarya of the receptor cells (Naessen, 1971). With age, these intraepithelial vessels regress and the epithelium becomes avascular. In adulthood, pigment granules are evident in the cytoplasm of sustentacular cells—granules that increase in number in the elderly (Naessen, 1971).
In parallel with the integrity of the olfactory epithelium, the size of the olfactory bulb and a number of its laminae—most notably the glomerular layer—declines with age in humans and other animals (Bhatnagar et al., 1987; Yousem et al., 1998; Sama et al., 2008). While this decline may reflect, to some degree, generalized atrophy, loss of neuronal elements, and increases in astroglia, most of the decline appears to be secondary to damage to the olfactory neuroepithelium from nasal infections, chronic rhinitis, lack of airflow, and exposures to xenobiotics; (see Holt, 1917; Frühwald, 1935; Smith, 1935; Meurman, 1950; Liss and Gomez, 1958). Indeed, one can use the number of glomeruli of autopsy specimens to infer the amount of destruction of the olfactory epithelium. In a classic study, Smith (1942) did just that, counting the number of glomeruli to estimate age-related losses of human olfactory receptors. In his examination of 205 olfactory bulbs from 121 autopsy specimens, he concluded that the loss of the olfactory nerves begins soon after birth and continues throughout life at the rate of approximately 1% per year. However, considerable variability was noted at all ages and a reassessment of his data using medians rather than means suggests that glomerular loss is most evident after the fifth decade of life, more or less paralleling what is shown in Figure 3 for odor identification.Bhatnagar et al. (1987) quantitatively assessed the morphology of eight pairs of bulbs from women who died between the ages of 25 and 102 years. Corresponding bulb volumes, estimated for the ages of 25, 60, and 95 years by linear regression, were 50.02, 43.35, and 36.68 mm3. Mean mitral cell numbers for these three age groups were 50,935, 32,718, and 14,501, respectively. Other cell types were not enumerated. As would be expected from the work of Smith (1942), the glomerular layer was markedly influenced by age and, in the older specimens, was discontinuous and evident only in the rostral areas of the bulb.Some studies have noted, in brains from non-demented older persons, neurofibrillary tangles in the olfactory bulb that increase as a function of age. For example, Kishikawa et al. (1990) observed such tangles in 35.3% of olfactory bulbs from 133 individuals ranging from 40 to 91 years (mean = 64.3 years), only one of whom had dementia. Most of the tangles were within the anterior olfactory nucleus, although a few were found in mitral and tufted cells. This percentage increased to 40.5% when only those over the age of 50 years were included in the sample. Similar types of pathology have been noted in autopsied olfactory bulbs from young persons who had lived in highly polluted regions of Mexico City, in some cases in association with nanoparticles that have entered into the bulbs via the olfactory fila (Calderon-Garciduenas et al., 2010).In the first of a series of important quantitative studies, Hinds and McNelly measured the volume of the glomerular, external plexiform, internal plexiform, and olfactory nerve layers of the olfactory bulb of Sprague Dawley rats at 3, 12, 24, 27, and 30 months of age (Hinds and McNelly, 1977). They also assessed the number of mitral cells and the volume of their nuclei, cell bodies, and dendritic trees, as well as the total length and mean cross-sectional area of the associated dendrites. Until the age of 24 months, a ~50% developmental increase in the volumes of each of the layers was observed, as was a doubling in the size of the volumes of the cell bodies and dendritic trees of the mitral cells. From 24 to 30 months, the volume of olfactory bulb layers decreased. Subsequently, the number of mitral cells also decreased. Although the total volume of mitral cell dendritic trees declined slightly from 24 to 27 months, the volume of individual mitral cell dendritic trees, as well as cell body and nuclear size, increased, presumably reflecting compensation for the decrease in mitral cell numbers.In a subsequent study, these general findings were replicated in the Charles River rat strain (Hinds and McNelly, 1981), save for a lack of a decline in mitral cell number in the older animals. Concurrent assessment was also made of alterations in the olfactory epithelium. After 18 months, olfactory bulb volumes declined and, after 24 months, decreases in the average volumes of the mitral cell bodies and the glomerular dendrites were observed. A comparison of regression lines for changes in number of olfactory receptors on the septum with that of the size of mitral cell bodies suggested that the decline in receptor number began several months before the decline in mitral cell size. This implied that the bulbar changes were in response to the epithelial changes. In the remaining olfactory receptor cells, an increase in the number of synapses per cell within the glomeruli occurred in the oldest rats evaluated, implying compensatory responses.Age-related changes in the volume of human olfactory bulbs have also been documented in vivo using magnetic resonance imaging (MRI) (Yousem et al., 1998; Buschhuter et al., 2008). However, such decrements are not specific to aging, are variable, and are plastic to some degree. Thus, olfactory bulb volume is reduced in cigarette smokers (Schriever et al., 2013) and in those with a number of neurological diseases or other disorders (Yousem et al., 1995b). These include acute depression (Negoias et al., 2010), Alzheimer's disease (Thomann et al., 2009), childhood abuse (Croy et al., 2013), chronic sinusitis (Rombaux et al., 2008), congential anosmia with and without Kallmann syndrome (Yousem et al., 1993, 1996; Abolmaali et al., 2002; Koenigkam-Santos et al., 2011; Levy et al., 2013), epilepsy (Hummel et al., 2012), head trauma (Yousem et al., 1995a; Doty et al., 1997; Landis et al., 2005; Jiang et al., 2009), multiple sclerosis (Goektas et al., 2011; Schmidt et al., 2011), Parkinson's disease (Wang et al., 2011b; Brodoehl et al., 2012), polyposis (Herzallah et al., 2013), schizophrenia (Turetsky et al., 2003; Nguyen et al., 2011), and prior upper respiratory infections associated with chronic smell loss (Rombaux et al., 2009). Such studies strongly suggest that olfactory bulb volume is a marker for olfactory function in general (Yousem et al., 1998; Turetsky et al., 2003; Buschhuter et al., 2008; Haehner et al., 2008; Hummel et al., 2011; Rombaux et al., 2012). Evidence of plasticity comes from observations that over time the shrinkage of olfactory bulbs in humans due to rhinosinusitis can be reversed as a result of treatment (Gudziol et al., 2009) and that rodent intrabulbar circuitry can recover from occlusion after reinstating nasal patency (Cummings and Belluscio, 2010).
Changes in central brain regions involved in olfactory processing
It is widely appreciated that aging is accompanied by decreased brain weight, cortical thickness, white matter integrity, and transmitter activity, and increased neuronal vulnerability, including early changes within brain structures associated with olfactory system processing (Kemper, 1984). Among such changes are disproportionate decrements in the volume of the hippocampus, amygdala, piriform cortex, anterior olfactory nucleus, and frontal poles of the brain. In a cohort of non-demented subjects ranging in age from 51 to 77 years, Segura et al. (2013) found that UPSIT scores were significantly correlated with the volume of the right amygdala and bilaterally with the volume of gray matter in the perirhinal and entorhinal cortices. Such scores were also inversely correlated with cortical thickness in the postcentral gyrus and with fractional anisotropy and mean diffusivity levels in the splenum of the corpus callosum and the superior longitudinal fasciculi.A number of age-related neurodegenerative disease pathologies, including abnormal deposits of tau and α-synuclein, have been associated with olfactory dysfunction in older non-demented persons, suggesting that some age-related alterations may reflect “pre-clinical” neurodegenerative disease. For example, in a longitudinal clinicopathological study of 122 non-demented subjects, Wilson et al. (2007a) found inverse correlations between B-SIT scores obtained before death and the post-mortem density of neurofibrillary tangles in the entorhinal cortex, the CA1 subfield of the hippocampus, and the subiculum. Similar associations were found by this group between pre-mortem B-SIT scores and post-mortem measures of Lewy bodies within limbic and cortical brain regions (Wilson et al., 2011b), leading the authors to conclude that olfactory function is impaired in Lewy body disease even in otherwise asymptomatic individuals.Persons with mild cognitive impairment (MCI) who convert to AD typically have more smell loss than MCI patients who do not convert (Croy et al., 2009). In AD, tau-related neurofibrillary pathology seems to be more closely linked to olfactory dysfunction than β-amyloid plaque pathology. Thus, some studies find no direct associations between the AD-related decrement in odor identification ability and brain β-amyloid, as measured by PET imaging of Pittsburgh compound B, an in vivo marker of brain amyloid levels (Bahar-Fuchs et al., 2010). This observation is consistent with post-mortem studies which, after controlling for the adverse influences of tau, find no strong associations between pre-mortem olfactory function and post-mortem levels of β-amyloid in olfactory eloquent brain regions of older individuals (Wilson et al., 2007a). It is noteworthy that anosmia, per se, is correlated with wide spread changes in gray matter within olfaction-related structures, including the piriform cortex, insular cortex, OFC, medial prefrontal cortex, hippocampus, parahippocampal gyrus, supramarginal gyrus, nucleus accumbens, subcallosal gyrus, and the medial and dorsolateral prefrontal cortices (Bitter et al., 2010).Functional imaging studies, such as those employing fMRI and positron emission tomography (PET), also demonstrate age-related changes in the processing of olfactory information, as reflected by decrements in odor-induced activation in central olfactory pathways. It should be noted, however, that such decrements need not be indicative of the locus of dysfunction. This is because the activity of a given central brain region often depends upon input from other brain regions that themselves may be compromised. Nevertheless, such imaging does represent the overall functioning of the system. Yousem et al., in a pioneering fMRI study, found that odors activated fewer voxels within the right inferior frontal and left and right superior frontal and perisylvian zones in old than in young persons (Yousem et al., 1999). Subsequently, Suzuki and his associates noted less fMRI odor-induced activation in 6 older persons than in 6 younger persons during an odor discrimination task in a region within the left orbital pole (Suzuki et al., 2001). Wang et al. (2005) found age-related decreases in activation in structures comprising the primary olfactory cortex, most notably in the right amygdala and piriform and periamygdaloid cortices (Figure 13). These investigators chose subjects whose UPSIT scores were within the normal age-adjusted range, although slightly lower scores were evident in the 11 young subjects (mean age = 23.9) than in the 8 older subjects (mean age = 66.4); respective UPSIT means = 37.3 and 34.1, p = 0.0004. More recently, Wong et al. (2010) found that a measure of nigrostriatal denervation in healthy elderly persons over the age 60 years, as determined by PET imaging of the brain dopamine transporter (DAT), was significantly correlated with UPSIT scores, suggesting that age-related declines in nigrostriatal function may account, in part, for age-related losses in smell ability.
It is well established that age-related changes occur in numerous enzyme, neurotransmitter, and neuromodulator systems within the brain. In many cases, the largest age-related decline occurs before the age of 60 years, as exemplified by enzymes involved in the synthesis of GABA (glutamate decarboxylase), acetylcholine (choline acetyltransferase), and both norepinephrine and dopamine (tyrosine hydroxylase) (Selkoe and Kosik, 1984). Hence, significant neurochemical changes are likely present prior to the onset of neuropathology and cognitive and motor phenotypes associated such age-related diseases as AD and PD. This implies that some such changes may “prime” the organism or lower the threshold for adverse influences from neural insults, mutations, and other deleterious factors in the elderly and could be, in fact, a critical substrate for the so-called “preclinical” stages of some age-related neurodegenerative diseases. Importantly, such neurochemical changes may be region specific, preferentially involving, for example, limbic structures early in the aging process (Strong, 1998). Imaging studies suggest that binding sites for a number of neurotransmitters are significantly decreased in the brains of older persons (Dewey et al., 1990; Rosier et al., 1996; Volkow et al., 2000).While several age-related neurotransmitter deficiencies may contribute to the olfactory loss observed in elderly persons, one system stands out as being particularly prepotent—the cholinergic system. Acetylcholine is intimately involved in the modulation of olfactory function, such as increasing contrast and synchronization of odor-induced activity from the bulb to the piriform cortex and facilitating attention, odor learning, memory, and cortical plasticity (de Almeida et al., 2013). Cholinergic projections reach all sectors of the olfactory system from origins within the medial septum, the nucleus basalis of Meynert, and the horizontal and vertical diagonal band of Broca (Schliebs and Arendt, 2011). Patients with MCI exhibit olfactory deficits and cholinergic dysfunction prior to the onset of AD—dysfunction which is unaccompanied by significant cell loss (Schliebs and Arendt, 2011). Interestingly, cholinergic neurons directly modulate neural activity within the olfactory bulb and tonically inhibit, along with some other neurotransmitters, the activity of microglial cells critical for immune responses to brain damage and foreign agents (Doty, 2012a). When such modulation is significantly perturbed, the release of inhibition on the microglial cells can occur, resulting in the secretion of inflammatory mediators and other factors which, in extreme instances, can be deleterious to neurons (Tang et al., 2007; Lalancette-Hebert et al., 2009).It is noteworthy that the relative magnitude of olfactory deficits of a number of neurodegenerative and neurodevelopmental diseases appears to be associated with the relative damage to the basal cholinergic system. Such disorders include AD, PD, Down syndrome, Parkinson-Dementia complex of Guam, Korsakoff syndrome, amyotrophic lateral sclerosis, schizophrenia, and progressive supranuclear palsy (for olfactory test scores, see, e.g., Mair et al., 1986; Doty et al., 1987, 1988, 1991, 1993; Kopala et al., 1994; Sajjadian et al., 1994; Wenning et al., 1995; McKeown et al., 1996; for quantitative assessments of basal cholinergic cell losses or volumes, see Arendt et al., 1983; Nakano and Hirano, 1983, 1984; Casanova et al., 1985; Rogers et al., 1985; Vogels et al., 1990; Yoshida et al., 1992; Kasashima and Oda, 2003). Age-related damage to the nucleus basalis has also been observed, although its magnitude is not generally as marked as that seen in AD and PD.
Conclusion
This review addressed the functional and pathophysiological changes that occur in the human olfactory system as a result of age. Basic information about the anatomy, physiology, and measurement of this primary sensory system was provided, along with a general overview of the nature of age-related changes that occur in olfactory perception. Numerous factors that likely contribute to such changes were assessed, including changes in autonomic control of nasal engorgement, increased propensity for nasal disease, cumulative damage to the olfactory epithelium from environmental insults, decrements in protective metabolizing enzymes in the olfactory mucosa, occlusion of the foramina of the cribriform plate, loss of selectivity of olfactory receptor neurons to odorants, changes in neurotransmitter and neuromodulator systems, and neuropathological processes such as the expression of aberrant proteins associated with such neurodegenerative diseases as AD and PD. As apparent from the research examined in this review, it is likely that there are multiple determinants of the olfactory loss of older persons, although the relative importance of each is yet to be established.
Author contributions
Dr. Doty wrote the first draft of the manuscript. Dr. Kamath contributed to the literature review and to the writing of two subsequent drafts. Both authors were involved in the writing of the final manuscript.
Conflict of interest statement
Dr. Doty is the President of, and major shareholder in, Sensonics International, a corporation that manufactures and distributes chemosensory test equipment and products, including the commercial version of the University of Pennsylvania Smell Identification Test (UPSIT) and a number of its clones. Dr. Kamath declares no commercial or financial relationships that could be construed as a potential conflict of interest.
Authors: Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Carlos Henríquez-Roldán; Norma Osnaya; Angelica González-Maciel; Rafael Reynoso-Robles; Rafael Villarreal-Calderon; Lou Herritt; Diane Brooks; Sheyla Keefe; Juan Palacios-Moreno; Rodolfo Villarreal-Calderon; Ricardo Torres-Jardón; Humberto Medina-Cortina; Ricardo Delgado-Chávez; Mario Aiello-Mora; Robert R Maronpot; Richard L Doty Journal: Exp Toxicol Pathol Date: 2009-03-17
Authors: David W Kern; Kristen E Wroblewski; L Philip Schumm; Jayant M Pinto; Rachel C Chen; Martha K McClintock Journal: J Gerontol B Psychol Sci Soc Sci Date: 2014-11 Impact factor: 4.077
Authors: Marta Ortega-Martínez; Laura E Rodríguez-Flores; Adriana Ancer-Arellano; Ricardo M Cerda-Flores; Carlos de-la-Garza-González; Jesús Ancer-Rodríguez; Gilberto Jaramillo-Rangel Journal: Lung Date: 2016-05-10 Impact factor: 2.584
Authors: Kimia G Ganjaei; Zachary M Soler; Elliott D Mappus; Mitchell L Worley; Nicholas R Rowan; Guilherme J M Garcia; Lois J Matthews; Judy R Dubno; Mark A Eckert; Rodney J Schlosser Journal: Rhinology Date: 2019-04-01 Impact factor: 3.681